Target intelligence / Profile preview

Tocotrienol (null)

Target
null
Molecular classification
Other (vitamin E analog/small molecule antioxidant)
01

Overview

Tocotrienols are a subclass of vitamin E molecules, distinct from tocopherols in their unsaturated side chain, comprised of four isomers (alpha, beta, gamma, delta) each with varying methylation patterns on the chromanol ring. They are found in plant sources such as palm oil, rice bran, and annatto, and are of interest for their potent antioxidant properties, higher cellular uptake compared to tocopherols, and potential physiological effects such as cholesterol lowering and anti-cancer activities in preclinical models. Tocotrienols are often studied as dietary supplements or nutraceuticals, rather than as conventional drug targets, and thus are not classified as therapeutic targets like receptors, enzymes, or transporters in drug discovery. If your intent is to capture *protein*, *receptor,* or *enzyme* drug targets, tocotrienols do not fit these criteria, and the entry is considered *incorrect* for listing as a canonical drug target.

Other names
TocotrienolsVitamin E (specific to the tocotrienol forms)Alpha-tocotrienol, beta-tocotrienol, gamma-tocotrienol, delta-tocotrienolT3 (common informal abbreviation)Unsaturated vitamin E
02

Mechanism of action

As small molecules, tocotrienols are thought to exert their effect mainly by: - Scavenging free radicals (antioxidant) - Inhibiting HMG-CoA reductase (cholesterol synthesis) to some degree (in vitro/in vivo evidence) - Modulating cell signaling pathways, possibly leading to anti-proliferative, anti-angiogenic, and pro-apoptotic effects in cancer models

03

Biological functions

Antioxidant activityModulation of lipid peroxidationCholesterol-loweringPotential anti-cancer effectsNeuroprotection (studied, not established)Modulation of cell signaling
04

Disease associations

Cardiovascular disease (studied for cholesterol lowering)Cancer (studied in models for anti-cancer/anti-angiogenic activity)Neurodegenerative disease (studied, especially in animal models)Other chronic diseases linked to oxidative stress
05

Safety considerations

Generally regarded as safe at nutritional and supplemental doses.High doses could, theoretically, increase bleeding risk due to vitamin E’s effects on platelet aggregation (based on vitamin E overall; specific risk for tocotrienols not well defined).There are no major, well-established unique safety concerns specific to tocotrienols distinct from tocopherols
06

Interacting drugs

None established as canonical "interacting drugs," since tocotrienols are not a protein or classical drug target. They may interact with statins or anticoagulants via physiological mechanisms, but not as a molecular target
07

Biomarkers

No established biomarkers for patient selection or efficacy monitoring. Serum tocotrienol levels can be measured for pharmacokinetic assessment.

Beyond the preview

Go deeper on Tocotrienol (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tocotrienol (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call